UNSPSC 51333901: Quinagolide

This classification denotes an antipsychotic agent with the molecular formula C20H33N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80Q9QWN15M, chemically known as sulfamide, n,n-diethyl-n-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)-, (3-alpha,4a-alpha,10a-beta)-(+-)- but generally known as quinagolide, which bears US NIH Compound Identifier 55645. European Medicines Agency schedules Quinagolide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10199MIG.

UNSPSC 51333901 Quinagolide is a Commodity code that designates a specific pharmaceutical product, but the recent state and local procurement activity under this code does not reflect quinagolide procurement. Seminole County, Florida posted IFB60459723LAS in June 2026 for naloxone and drug deactivation systems — a public health supply acquisition with no connection to quinagolide, a dopamine agonist used in endocrinology. The mismatch suggests that either the code was misapplied to the opportunity or the code captures state and local procurement activity unrelated to its pharmaceutical namesake. State and local procurement systems occasionally tag opportunities with codes that do not align with actual goods or services being bought, particularly when commodity classifications within purchasing offices lack strict enforcement or when vendors enter incorrect codes in electronic submission systems.

The single identified opportunity shows Seminole County, a Florida county health department, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB closed July 26, 2023 (the source date appears to contain a data entry error, as the posting date is June 30, 2026, well after the closure date). Contractors must provide unit pricing for each line item, maintain workers' compensation and commercial general liability insurance, pass E-Verify compliance, and accept a three-month probationary termination clause. The contract runs two years with one optional renewal year. No recent activity beyond this single misfiled opportunity is present in the source. If your firm pursues state and local pharmaceutical procurement, verify UNSPSC coding before investing in bidding on opportunities tagged with this code.